These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 25054581)

  • 1. Medulloblastoma: recurrence and metastasis.
    Aref D; Croul S
    CNS Oncol; 2013 Jul; 2(4):377-85. PubMed ID: 25054581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Childhood medulloblastoma: the paradigm shift in molecular stratification and treatment profile.
    Sadighi Z; Vats T; Khatua S
    J Child Neurol; 2012 Oct; 27(10):1302-7. PubMed ID: 22826514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medulloblastoma in the age of molecular subgroups: a review.
    Juraschka K; Taylor MD
    J Neurosurg Pediatr; 2019 Oct; 24(4):353-363. PubMed ID: 31574483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hedgehogs, flies, Wnts and MYCs: the time has come for many things in medulloblastoma.
    Monje M; Beachy PA; Fisher PG
    J Clin Oncol; 2011 Apr; 29(11):1395-8. PubMed ID: 21357776
    [No Abstract]   [Full Text] [Related]  

  • 5. Medulloblastoma: what is the role of molecular genetics?
    Entz-Werle N; Carli ED; Ducassou S; Legrain M; Grill J; Dufour C
    Expert Rev Anticancer Ther; 2008 Jul; 8(7):1169-81. PubMed ID: 18588461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medulloblastoma in China: clinicopathologic analyses of SHH, WNT, and non-SHH/WNT molecular subgroups reveal different therapeutic responses to adjuvant chemotherapy.
    Zhang ZY; Xu J; Ren Y; Li KK; Ng HK; Mao Y; Zhong P; Yao Y; Zhou LF
    PLoS One; 2014; 9(6):e99490. PubMed ID: 24932704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Classification Improves Therapeutic Options for Infants and Young Children With Medulloblastoma.
    Bagchi A; Dhanda SK; Dunphy P; Sioson E; Robinson GW
    J Natl Compr Canc Netw; 2023 Aug; 21(10):1097-1105. PubMed ID: 37643637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Childhood Medulloblastoma: An Overview.
    Suk Y; Gwynne WD; Burns I; Venugopal C; Singh SK
    Methods Mol Biol; 2022; 2423():1-12. PubMed ID: 34978683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current therapy and new perspectives in the treatment of medulloblastoma.
    Whelan HT; Krouwer HG; Schmidt MH; Reichert KW; Kovnar EH
    Pediatr Neurol; 1998 Feb; 18(2):103-15. PubMed ID: 9535295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic effect of whole chromosomal aberration signatures in standard-risk, non-WNT/non-SHH medulloblastoma: a retrospective, molecular analysis of the HIT-SIOP PNET 4 trial.
    Goschzik T; Schwalbe EC; Hicks D; Smith A; Zur Muehlen A; Figarella-Branger D; Doz F; Rutkowski S; Lannering B; Pietsch T; Clifford SC
    Lancet Oncol; 2018 Dec; 19(12):1602-1616. PubMed ID: 30392813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evolution of the management of pediatric and adult medulloblastoma].
    Vigneron C; Entz-Werlé N; Lutz P; Spiegel A; Jannier S; Helfre S; Alapetite C; Coca A; Kehrli P; Noël G
    Cancer Radiother; 2015 Aug; 19(5):347-57; quiz 358-9, 362. PubMed ID: 26141663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New concepts in organ site research on medulloblastoma: genetics and genomics.
    Roussel MF
    Future Oncol; 2010 Aug; 6(8):1229-31. PubMed ID: 20799868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Subgrouping of Medulloblastoma: Impact Upon Research and Clinical Practice.
    Gupta T; Shirsat N; Jalali R
    Curr Pediatr Rev; 2015; 11(2):106-19. PubMed ID: 26133181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exclusive Hyperfractionated Radiation Therapy and Reduced Boost Volume for Standard-Risk Medulloblastoma: Pooled Analysis of the 2 French Multicentric Studies MSFOP98 and MSFOP 2007 and Correlation With Molecular Subgroups.
    Carrie C; Kieffer V; Figarella-Branger D; Masliah-Planchon J; Bolle S; Bernier V; Laprie A; Supiot S; Leseur J; Habrand JL; Alapetite C; Kerr C; Dufour C; Claude L; Chapet S; Huchet A; Bondiau PY; Escande A; Truc G; Nguyen TD; Pasteuris C; Vigneron C; Muracciole X; Bourdeaut F; Appay R; Dubray B; Colin C; Ferlay C; Dussart S; Chabaud S; Padovani L; ;
    Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1204-1217. PubMed ID: 32768563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical and nanoString-Based Subgrouping of Clinical Medulloblastoma Samples.
    D'Arcy CE; Nobre LF; Arnaldo A; Ramaswamy V; Taylor MD; Naz-Hazrati L; Hawkins CE
    J Neuropathol Exp Neurol; 2020 Apr; 79(4):437-447. PubMed ID: 32053195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Definition of disease-risk stratification groups in childhood medulloblastoma using combined clinical, pathologic, and molecular variables.
    Ellison DW; Kocak M; Dalton J; Megahed H; Lusher ME; Ryan SL; Zhao W; Nicholson SL; Taylor RE; Bailey S; Clifford SC
    J Clin Oncol; 2011 Apr; 29(11):1400-7. PubMed ID: 20921458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Medulloblastoma].
    Bouffet E; Frappaz D; Carrie C; Freycon F; Brunat-Mentigny M
    Pediatrie; 1991; 46(1):71-8. PubMed ID: 1851287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medulloblastoma: From Myth to Molecular.
    Ramaswamy V; Taylor MD
    J Clin Oncol; 2017 Jul; 35(21):2355-2363. PubMed ID: 28640708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissecting the genomic complexity underlying medulloblastoma.
    Jones DT; Jäger N; Kool M; Zichner T; Hutter B; Sultan M; Cho YJ; Pugh TJ; Hovestadt V; Stütz AM; Rausch T; Warnatz HJ; Ryzhova M; Bender S; Sturm D; Pleier S; Cin H; Pfaff E; Sieber L; Wittmann A; Remke M; Witt H; Hutter S; Tzaridis T; Weischenfeldt J; Raeder B; Avci M; Amstislavskiy V; Zapatka M; Weber UD; Wang Q; Lasitschka B; Bartholomae CC; Schmidt M; von Kalle C; Ast V; Lawerenz C; Eils J; Kabbe R; Benes V; van Sluis P; Koster J; Volckmann R; Shih D; Betts MJ; Russell RB; Coco S; Tonini GP; Schüller U; Hans V; Graf N; Kim YJ; Monoranu C; Roggendorf W; Unterberg A; Herold-Mende C; Milde T; Kulozik AE; von Deimling A; Witt O; Maass E; Rössler J; Ebinger M; Schuhmann MU; Frühwald MC; Hasselblatt M; Jabado N; Rutkowski S; von Bueren AO; Williamson D; Clifford SC; McCabe MG; Collins VP; Wolf S; Wiemann S; Lehrach H; Brors B; Scheurlen W; Felsberg J; Reifenberger G; Northcott PA; Taylor MD; Meyerson M; Pomeroy SL; Yaspo ML; Korbel JO; Korshunov A; Eils R; Pfister SM; Lichter P
    Nature; 2012 Aug; 488(7409):100-5. PubMed ID: 22832583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signaling pathway deregulation and molecular alterations across pediatric medulloblastomas.
    Lhermitte B; Blandin AF; Coca A; Guerin E; Durand A; Entz-Werlé N
    Neurochirurgie; 2021 Feb; 67(1):39-45. PubMed ID: 29776650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.